Pancreatic Cancer Research

ResearcherXinjiang Medical UniversityNo recent work listed

Hai Lan Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-6284-6946; OpenAlex author ID A5102923832. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 5

  1. LncRNA MBNL1-AS1 Suppresses Cell Proliferation and Metastasis of Pancreatic Adenocarcinoma through Targeting Carcinogenic miR-301b-3p. Co-author DOI 10.1155/2023/6785005↗
  2. miR-146a Inhibited Pancreatic Cancer Cell Proliferation by Targeting SOX7. Co-author DOI 10.1155/2022/2240605↗
  3. Gli1 expression in pancreatic ductal adenocarcinoma and its clinical significance. Co-author DOI 10.4238/2015.october.9.21↗
  4. Knockdown of OCT4 suppresses the growth and invasion of pancreatic cancer cells through inhibition of the AKT pathway. Co-author DOI 10.3892/mmr.2014.2367↗
  5. Clinical significance of pituitary tumor transforming gene 1 and transgelin-2 in pancreatic cancer. Co-author DOI 10.1177/039463201302600114↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tieying He · 3 shared papers, 2014–2023 · strength 0.43
  2. Qilong Chen · 2 shared papers, 2022–2023 · strength 0.39
  3. Chouman Sulidankazha · 2 shared papers, 2022–2023 · strength 0.39
  4. Wei Han · 1 shared paper, 2023 · strength 0.22
  5. Yimamumaimaitijiang Abula · 1 shared paper, 2015 · strength 0.05
  6. Renyi Qin · 1 shared paper, 2015 · strength 0.05
  7. Kai Li · 1 shared paper, 2015 · strength 0.05
  8. Xin‐Jian Xu · 1 shared paper, 2014 · strength 0.04
  9. Hao Wen · 1 shared paper, 2014 · strength 0.04
  10. Xiyan Wang · 1 shared paper, 2014 · strength 0.04
  11. Qilong Chen · 1 shared paper, 2014 · strength 0.04
  12. L-D. Su · 1 shared paper, 2013 · strength 0.04
  13. Ken Chen · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.